EUVIMEDEUVIMED entdecken
Crossref

Candesartan upregulates angiotensin‐converting enzyme 2 in kidneys of male animals by decreased ubiquitination

Ping Wang iD, Zhiyun Ren iD, Weiwan Wang iD, Mingda Liu iD, Yutao Jia iD, Mingzhuo Zhang iD, Ying Xue iD, Chenyang Zhang iD, Jianteng Xu iD, Cheng Wang iD, Xiaoyan Wang iD

The FASEB Journal · 2024

DOI: 10.1096/fj.202302707r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Ping Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Core Laboratory for Clinical Research, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme 2, Hypertension, Benzimidazoles, Biphenyl Compounds. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Nanjing Medical Science and Technology Development Fund, Postgraduate Research & Practice Innovation Program of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Candesartan is a common angiotensin‐II receptor‐1 blocker used for patients with cardiovascular and renal diseases. Angiotensin‐converting enzyme 2 (ACE2) is a negative regulator of blood pressure (BP), and also a major receptor for coronaviruses. To determine whether and how candesartan upregulates ACE2, we examined BP and ACE2 in multi‐organs from male and female C57BL/6J mice treated with candesartan (1 mg/kg, i.p.) for 7 days. Relative to the vehicle, candesartan lowered BP more in males than females; ACE2 protein abundances were increased in kidneys, not lungs, hearts, aorta, liver, spleen, brain, or serum, only from males. Ace2‐mRNA was similar in kidneys. Candesartan also decreased BP in normal, hypertensive, and nephrotic male rats. The renal ACE2 was increased by the drug in normal and nephrotic male rats but not spontaneously hypertensive ones. In male mouse kidneys, ACE2 was distributed at sodium‐hydrogen‐exchanger‐3 positive proximal‐convoluted‐tubules; ACE2‐ubiquitination was decreased by candesartan, accompanied with increased ubiquitin‐specific‐protease‐48 (USP48). In candesartan‐treated mouse renal proximal‐convoluted‐tubule cells, ACE2 abundances and activities were increased while ACE2‐ubiquitination and colocalization with lysosomal and proteosomal markers were decreased. The silence of USP48 by siRNA caused a reduction of ACE2 in the cells. Thus, the sex‐differential ACE2 upregulation by candesartan in kidney from males may be due to the decreased ACE2‐ubiquitination, associated with USP48, and consequent degradation in lysosomes and proteosomes. This is a novel mechanism and may shed light on candesartan‐like‐drug choice in men and women prone to coronavirus infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin-Converting Enzyme 2HypertensionBenzimidazolesBiphenyl CompoundsHumansFemaleMaleRatsMiceAnimalsMice, Inbred C57BLKidneyTetrazolesUbiquitination

Stichwörter der Autor:innen

ACE2USP48candesartankidneylungubiquitination

Substanzen

Angiotensin-Converting Enzyme 2candesartanTetrazolesBenzimidazolesBiphenyl Compounds

Autor:innen und Institutionen

  • The Core Laboratory for Clinical Research, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Nephrology, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Neurology, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China.
  • Laboratory Division, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China.
  • The Department of Pulmonary and Critical Care Medicine, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China.

ORCID-Profile: Ping Wang, Zhiyun Ren, Weiwan Wang, Mingda Liu, Yutao Jia, Mingzhuo Zhang, Ying Xue, Chenyang Zhang, Jianteng Xu, Cheng Wang, Xiaoyan Wang

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • Nanjing Medical Science and Technology Development Fund
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province
  • National Natural Science Foundation of China

Zitieren

APA

Wang, P., Ren, Z., Wang, W., Liu, M., Jia, Y., Zhang, M., Xue, Y., Zhang, C., Xu, J., Wang, C., & Wang, X. (2024). Candesartan upregulates angiotensin‐converting enzyme 2 in kidneys of male animals by decreased ubiquitination. The FASEB Journal. https://doi.org/10.1096/fj.202302707r

Vancouver

Wang P, Ren Z, Wang W, Liu M, Jia Y, Zhang M, et al. Candesartan upregulates angiotensin‐converting enzyme 2 in kidneys of male animals by decreased ubiquitination. The FASEB Journal. 2024. doi:10.1096/fj.202302707r

BibTeX
@article{Wang2024,
  author = {Wang, Ping and Ren, Zhiyun and Wang, Weiwan and Liu, Mingda and Jia, Yutao and Zhang, Mingzhuo and Xue, Ying and Zhang, Chenyang and Xu, Jianteng and Wang, Cheng and Wang, Xiaoyan},
  title = {Candesartan upregulates angiotensin‐converting enzyme 2 in kidneys of male animals by decreased ubiquitination},
  journal = {The FASEB Journal},
  year = {2024},
  doi = {10.1096/fj.202302707r}
}
Kostenlos starten →